Related references
Note: Only part of the references are listed.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Alin Stirban et al.
MOLECULAR METABOLISM (2014)
Advanced glycation endproducts and their pathogenic roles in neurological disorders
Gerald Muench et al.
AMINO ACIDS (2012)
AGEs Induce Cell Death via Oxidative and Endoplasmic Reticulum Stresses in Both Human SH-SY5Y Neuroblastoma Cells and Rat Cortical Neurons
Qing-Qing Yin et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Protective Effects of Salvianolic Acid B on Schwann Cells Apoptosis Induced by High Glucose
Lian-Qing Sun et al.
NEUROCHEMICAL RESEARCH (2012)
Erythropoietin in neonatal brain protection: The past, the present and the future
Abdullah Kumral et al.
BRAIN & DEVELOPMENT (2011)
AGE restriction in diabetes mellitus: a paradigm shift
Helen Vlassara et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
Nitric oxide prevents axonal degeneration by inducing HIF-1-dependent expression of erythropoietin
Sanjay C. Keswani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress
Jianfei Chen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of Cisplatin-induced neuropathy
Min-Suk Yoon et al.
BMC NEUROSCIENCE (2009)
Effect of panaxydol on hypoxia-induced cell death and expression and secretion of neurotrophic factors (NTFs) in hypoxic primary cultured Schwann cells
Hao Zhu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies
Kenneth Maiese et al.
PROGRESS IN NEUROBIOLOGY (2008)
The role of erythropoietin in central and peripheral nerve injury
Marios G. Lykissas et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2007)
Schwann cells: Activated peripheral glia and their role in neuropathic pain
Wendy Marie Campana
BRAIN BEHAVIOR AND IMMUNITY (2007)
Coffee and Maillard products activate NF-κB in macrophages via H2O2 production
Sonja Muscat et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress
Andrea M. Vincent et al.
ENDOCRINOLOGY (2007)
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes
Yong Ding et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Schwann cells express motor and sensory phenotypes that regulate axon regeneration
A. Hoke et al.
JOURNAL OF NEUROSCIENCE (2006)
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease
M Hasselblatt et al.
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2006)
Erythropoietin reduces Schwann cell TNF-α, Wallerian degeneration and pain-related behaviors after peripheral nerve injury
WM Campana et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Schwann cells: Origins and role in axonal maintenance and regeneration
Kanav Bhatheja et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury
XQ Li et al.
GLIA (2005)
A novel endogenous erythropoietin mediated pathway prevents axonal degeneration
SC Keswani et al.
ANNALS OF NEUROLOGY (2004)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)